Kaye Edward M. MD bought CYTK
July 15, 2026 · Form 4 insider transaction
Kaye Edward M. MD bought 151 shares of Cytokinetics, Incorporated at $82.62 per share, a transaction worth $12.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
151
Price
$82.62
Total value
$12.5K
InsiderKaye Edward M. MD
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 15, 2026
Filing dateJuly 16, 2026
Shares owned after10,434
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant.